Join the High Cholesterol group to help and get support from people like you.
High Cholesterol News (Page 4)
Related terms: Cholesteremia, Cholesterol, Elevated Levels, Cholesterol, High, Cholesterolemia, Familial Hypercholesterolemia, Hypercholesterolemia, Hypercholesterolemia, Familial, Hyperlipidemia, Lipid Metabolism Disorders
FDA Approves Praluent (alirocumab) to Treat Certain Patients with High Cholesterol
July 24, 2015 – The U.S. Food and Drug Administration today approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new class of drugs known as proprotein...
FDA Medwatch Alert: Red Yeast Rice by Doctor’s Best: Recall - Undeclared Lovastatin
ISSUE: Doctor’s Best is voluntarily recalling lot 3121005 (7379 bottles) of Red Yeast Rice dietary supplement, 600 mg Capsules, 120-count bottles to the retail level. Doctor’s Best Red Yeast Rice has ...
FDA Approves Merck’s Liptruzet (ezetimibe and atorvastatin), a New Product That Can Help Lower LDL Cholesterol
Friday, May 3, 2013 - Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Liptruzet (ezetimibe and atorvastatin)...
FDA Approves New Orphan Drug Kynamro to Treat Inherited Cholesterol Disorder
January 29, 2013 – The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type...
FDA Approves Juxtapid - New Orphan Drug for Rare Cholesterol Disorder
December 26, 2012 – On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and...
FDA Medwatch Alert: Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance
ISSUE: On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail l...
FDA Approves Combination Therapy Juvisync
SILVER SPRING, Md., Oct. 7, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription...
Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juice or Diet Soft Drinks
PARSIPPANY, N.J., July 25, 2011 /PRNewswire/ – Daiichi Sankyo, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol...
FDA Approves Crestor to Reduce Stroke, Heart Attack Risk
Approval based on JUPITER study which evaluated Crestor in a previously unstudied population WILMINGTON, Del., Feb. 8 /PRNewswire-FirstCall/ – AstraZeneca today announced that the US Food and Drug...
FDA Medwatch Alert: Cholestrix
[Posted August 09, 2007] FDA warns consumers and healthcare professionals to avoid using Red Yeast Rice and Red Yeast Rice/Policosonal Complex, sold by Swanson Healthcare Products, Inc. and...
Further information
Related condition support groups
High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Cardiovascular Conditions and Disorders
Related drug support groups
atorvastatin, simvastatin, Repatha, Crestor, pravastatin, Zetia, ezetimibe, cholestyramine, niacin, rosuvastatin, garcinia cambogia, Leqvio, garlic